Skip to main content

Anal Sphincter Injury

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

SAGICO
SAGICOFOSTER CITY, CA
1 program
No episiotomyN/A1 trial
Active Trials
NCT02356237TerminatedEst. May 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SAGICONo episiotomy

Clinical Trials (1)

NCT02356237SAGICONo episiotomy

The Effect of Episiotomy on Maternal and Fetal Outcomes (EPITRIAL)

Start: Jun 2015Est. completion: May 2018
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.